An improved total synthesis of spermatinamine, an inhibitor of isoprenylcysteine carboxy methyltransferase

Nisar Ullah; Shamsuddeen A. Haladu; Basem A. Mosa

doi:10.1016/j.tetlet.2010.10.164

An improved total synthesis of spermatinamine, an inhibitor of isoprenylcysteine carboxy methyltransferase

Nisar Ullah^*, Shamsuddeen A. Haladu, Basem A. Mosa

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

An improved total synthesis of spermatinamine, an inhibitor of the anticancer target, isoprenylcysteine carboxy methyltransferase (Icmt) was accomplished from the commercially available 3,4-dibromo-4-hydroxybenzaldehyde via a high yielding reaction sequence in an overall yield of 31%.

Original language	English (US)
Pages (from-to)	212-214
Number of pages	3
Journal	Tetrahedron Letters
Volume	52
Issue number	2
DOIs	https://doi.org/10.1016/j.tetlet.2010.10.164
State	Published - Jan 12 2011

Keywords

Anticancer drug
Azlactone formation
Icmt inhibitor
Spermatinamine

ASJC Scopus subject areas

Drug Discovery
Biochemistry
Organic Chemistry

Access to Document

10.1016/j.tetlet.2010.10.164

Cite this

@article{daafb1e9aff84b2bbbcd7dc5818b6caa,

title = "An improved total synthesis of spermatinamine, an inhibitor of isoprenylcysteine carboxy methyltransferase",

abstract = "An improved total synthesis of spermatinamine, an inhibitor of the anticancer target, isoprenylcysteine carboxy methyltransferase (Icmt) was accomplished from the commercially available 3,4-dibromo-4-hydroxybenzaldehyde via a high yielding reaction sequence in an overall yield of 31%.",

keywords = "Anticancer drug, Azlactone formation, Icmt inhibitor, Spermatinamine",

author = "Nisar Ullah and Haladu, {Shamsuddeen A.} and Mosa, {Basem A.}",

year = "2011",

month = jan,

day = "12",

doi = "10.1016/j.tetlet.2010.10.164",

language = "English (US)",

volume = "52",

pages = "212--214",

journal = "Tetrahedron Letters",

issn = "0040-4039",

publisher = "Elsevier Ltd",

number = "2",

}

TY - JOUR

T1 - An improved total synthesis of spermatinamine, an inhibitor of isoprenylcysteine carboxy methyltransferase

AU - Ullah, Nisar

AU - Haladu, Shamsuddeen A.

AU - Mosa, Basem A.

PY - 2011/1/12

Y1 - 2011/1/12

N2 - An improved total synthesis of spermatinamine, an inhibitor of the anticancer target, isoprenylcysteine carboxy methyltransferase (Icmt) was accomplished from the commercially available 3,4-dibromo-4-hydroxybenzaldehyde via a high yielding reaction sequence in an overall yield of 31%.

AB - An improved total synthesis of spermatinamine, an inhibitor of the anticancer target, isoprenylcysteine carboxy methyltransferase (Icmt) was accomplished from the commercially available 3,4-dibromo-4-hydroxybenzaldehyde via a high yielding reaction sequence in an overall yield of 31%.

KW - Anticancer drug

KW - Azlactone formation

KW - Icmt inhibitor

KW - Spermatinamine

UR - http://www.scopus.com/inward/record.url?scp=78650019754&partnerID=8YFLogxK

U2 - 10.1016/j.tetlet.2010.10.164

DO - 10.1016/j.tetlet.2010.10.164

M3 - Article

AN - SCOPUS:78650019754

SN - 0040-4039

VL - 52

SP - 212

EP - 214

JO - Tetrahedron Letters

JF - Tetrahedron Letters

IS - 2

ER -

An improved total synthesis of spermatinamine, an inhibitor of isoprenylcysteine carboxy methyltransferase

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this